BLCO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical...

Stats
Today's Volume	251 275
Average Volume	473 467
Market Cap	5.18B
EPS	$0 ( 2024-02-21 )
Next earnings date	( $0.0900 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-19.95
ATR14	$0.0110 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-29	Robertson Russel C	Buy	1 481	Common Shares, No Par Value
2024-03-29	Paulson John	Buy	1 264	Common Shares, No Par Value
2024-03-29	De Schutter Richard U	Buy	1 553	Common Shares, No Par Value
2024-03-05	Ling Karen	Buy	2 642	Common Shares, No Par Value
2024-02-27	Ling Karen	Buy	0

INSIDER POWER
-9.45
Last 94 transactions
Buy: 2 828 512 \| Sell: 8 825 819

Volume Correlation

Long: -0.53 (weak negative)

Short: 0.05 (neutral)

Signal:(37.986) Neutral

Bausch + Lomb Corporation Correlation

10 Most Positive Correlations
BPMP	0.903
ARC	0.848
BMA	0.847
TPR	0.84
HSBC	0.834
BIP-PA	0.83
CMCM	0.829
BFS-PD	0.826
SUPV	0.818
ANF	0.818

10 Most Negative Correlations
EPV	-0.803

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bausch + Lomb Corporation Correlation - Currency/Commodity

0.49
( neutral )

0.33
( neutral )

0.00
( neutral )

0.48
( neutral )

0.39
( neutral )

0.71
( moderate )

Bausch + Lomb Corporation Financials

Annual	2023
Revenue:	$4.15B
Gross Profit:	$2.50B (60.40 %)
EPS:	$-0.740

Q4	2023
Revenue:	$1.17B
Gross Profit:	$712.00M (60.70 %)
EPS:	$-0.150

Q3	2023
Revenue:	$1.01B
Gross Profit:	$615.00M (61.07 %)
EPS:	$-0.240

Q2	2023
Revenue:	$1.04B
Gross Profit:	$618.00M (59.71 %)
EPS:	$-0.0913

Financial Reports:

No articles found.

Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Realtime updates for Bausch + Lomb Corporation [BLCO]

Upcoming Earnings Alert